Retrophin Names Dr. Horacio Plotkin CMO

New York-based Retrophin, a pharmaceutical company, has named Horacio Plotkin, MD, its chief medical officer, effective May 13, according to a Fort Mills Times report.

Advertisement

Most recently, Dr. Plotkin served as executive medical director of clinical research for Alexion Pharmaceuticals. He currently serves as adjunct associate professor of pediatrics and orthopedic surgery at the University of Nebraska Medical Center in Omaha.  

More Articles on Executive Appointments:

10 Spine Device Company Executive Moves
Sonoma Orthopedic Products Hires 3 New Executives
AAOS Names Eight New Executives

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Practice Management

Advertisement

Comments are closed.